Rad Neurim Pharmaceuticals Eec Limited
03900712
Healthy
No risk factors detected.
Details
Previously known as
Compliance
Last accounts
31/12/2025
dormant
Next accounts due
30/09/2027
Confirmation statement
Last: 22/12/2025
Due 05/01/2027
Industry
Officers
director · Since 22/12/1999
PROFESSOR/COMPANY DIRECTOR
ISRAELI · ISRAEL · Age 79
Former
corporate nominee director · Resigned 22/12/1999
corporate nominee secretary · Resigned 22/12/1999
director · Resigned 12/03/2003
director · Resigned 01/12/2024
Persons with Significant Control
Neurim Pharmaceuticals (1991) Ltd.
Or Building, 27 Habarzel Street, Tel Aviv, 6971039
Reg: 512705203 · Israeli Companies Registrar · Private Company
Notified 20/12/2016
Change History
Active
Private Limited Company
5TH FLOOR THAMES TOWER
READING
CompanyRankvs 39409+ SIC 99999 peers40
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£2
Balance sheet strength
Cash
£2
Cash in the bank
Net Current Assets
£2
Working capital
Current Assets
—
Current Liabilities
—
Balance Sheet